September 2 2013 – New pathway to treat colorectal cancer, pulmonary fibrosis

Israel researchers uncover secrets of how a certain white blood cell can flip from being a ‘good guy’ to a ‘bad guy’ in diseases with no current cure.

Doctoral student Danielle Karo-Atar studying macrophages at Tel Aviv University.

Doctoral student Danielle Karo-Atar studying macrophages at Tel Aviv University.

A type of white blood cell called a macrophage is one tricky customer. Expose macrophages to a certain stimulus and they’ll promote healing. But expose them to a different stimulus and they actually make the condition worse.

A team of Israeli researchers is making unprecedented progress in mapping the mechanism of these “good guy, bad guy” cells and understanding their role in the progression of two deadly diseases: colorectal cancer and idiopathic pulmonary fibrosis (IPF), an incurable lung condition.

Read the entire article at:

http://israel21c.org/health/new-pathway-to-treat-colorectal-cancer-pulmonary-fibrosis/

For more information about Idiopathic Pulmonary Fibrosis please visit our website www.ipftoday.com and don’t forget to like us on www.facebook.com/IPFToday

This entry was posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized and tagged , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>